Literature DB >> 33339198

Photo-Based Nanomedicines Using Polymeric Systems in the Field of Cancer Imaging and Therapy.

Patihul Husni1, Yuseon Shin1, Jae Chang Kim1, Kioh Kang1, Eun Seong Lee2, Yu Seok Youn3, Taofik Rusdiana4, Kyung Taek Oh1.   

Abstract

The use of photo-based nanomedicine in imaging and therapy has grown rapidly. The property of light in converting its energy into different forms has been exploited in the fields of optical imaging (OI) and phototherapy (PT) for diagnostic and therapeutic applications. The development of nanotechnology offers numerous advantages to overcome the challenges of OI and PT. Accordingly, in this review, we shed light on common photosensitive agents (PSAs) used in OI and PT; these include fluorescent and bioluminescent PSAs for OI or PT agents for photodynamic therapy (PDT) and photothermal therapy (PTT). We also describe photo-based nanotechnology systems that can be used in photo-based diagnostics and therapies by using various polymeric systems.

Entities:  

Keywords:  light; nanomedicine; optical imaging; photodynamic therapy; phototherapy; photothermal therapy

Year:  2020        PMID: 33339198     DOI: 10.3390/biomedicines8120618

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  3 in total

1.  Manganese-Doped Calcium Silicate Nanowire Composite Hydrogels for Melanoma Treatment and Wound Healing.

Authors:  Zhongcao Wu; Hui Zhuang; Bing Ma; Yin Xiao; Bahattin Koc; Yufang Zhu; Chengtie Wu
Journal:  Research (Wash D C)       Date:  2021-05-07

Review 2.  Recent Advances in pH- or/and Photo-Responsive Nanovehicles.

Authors:  Yuseon Shin; Patihul Husni; Kioh Kang; Dayoon Lee; Sehwa Lee; Eunseong Lee; Yuseok Youn; Kyungtaek Oh
Journal:  Pharmaceutics       Date:  2021-05-14       Impact factor: 6.321

3.  Escherichia coli adhesin protein-conjugated thermal responsive hybrid nanoparticles for photothermal and immunotherapy against cancer and its metastasis.

Authors:  Juyoung Hwang; Wei Zhang; Hae-Bin Park; Dhananjay Yadav; Yong Hyun Jeon; Jun-O Jin
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.